サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751180

ウィルムス腫瘍の世界市場レポート 2025年

Wilms Tumor Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
ウィルムス腫瘍の世界市場レポート 2025年
出版日: 2025年06月17日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ウィルムス腫瘍の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.8％で20億7,000万米ドルに成長します。予測期間における成長の背景には、個別化医療への注目の高まり、放射線治療技術の利用拡大、生活習慣に関連する危険因子の有病率の上昇、小児がん専門医の増加、ヘルスケア機関による啓発キャンペーンの拡大などがあります。予測期間中に予想される主な動向には、CAR-T細胞療法の開発、新規化学療法レジメンの導入、併用療法の拡大、バイオマーカー主導型診断の進歩、ウェアラブル健康モニタリング機器の統合などがあります。

小児がんの罹患率の増加は、今後数年間のウィルムス腫瘍市場の拡大を牽引すると予想されます。小児がんとは、0～14歳の小児に発生するがんを指し、さまざまな臓器や組織における細胞の異常増殖を特徴とします。有病率の増加は、環境汚染物質、遺伝的素因、感染症、免疫系の問題などの要因と関連しています。これらの症例は、早期診断、遺伝的要因、標的治療に関する貴重な洞察を提供し、患児の生存率の向上と生活の質の改善に貢献しています。例えば、2025年1月、米国を拠点とするがん研究団体Cancer Networkは、2025年に約9,550人の小児（0～14歳）ががんと診断され、1,050人が死亡すると予測しています。このように、小児がんの増加率がウィルムス腫瘍市場の成長を後押ししています。

ヘルスケア支出の増加は、ウィルムス腫瘍市場の成長を加速させると予測されています。ヘルスケア支出とは、特定の期間における医療サービス、機器、医薬品、ヘルスケアインフラへの財政投資の総額を指します。支出が増加傾向にあるのは、慢性疾患の有病率が高まり、高度な治療オプションに対するニーズが高まっているためです。ヘルスケア支出の増加は、早期診断、先進治療へのアクセス、専門医療を可能にすることにより、ウィルムス腫瘍のより良い治療を促進し、最終的に生存率を向上させる。また、継続的な研究、治療法の革新、的を絞った安価な医薬品へのアクセスも支援します。例えば、2024年5月、英国国家統計局は、2022～2023年にかけてのヘルスケア支出の名目増加率が5.6％であることを報告しました（2022年の増加率は0.9％）。このように、医療費の増加はウィルムス腫瘍市場の成長に大きく寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のウィルムス腫瘍のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界のウィルムス腫瘍市場：成長率分析
  • 世界のウィルムス腫瘍市場の実績：規模と成長、2019～2024年
  • 世界のウィルムス腫瘍市場の予測：規模と成長、2024～2029年、2034年
  • 世界のウィルムス腫瘍総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のウィルムス腫瘍市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 予後良好型組織像
  • 退形成型組織像
  • 世界のウィルムス腫瘍市場：ステージ別、実績と予測、2019～2024年、2024～2029年、2034年
  • ステージI
  • ステージII
  • ステージIII
  • ステージIV
  • ステージV
  • 世界のウィルムス腫瘍市場：診断別、実績と予測、2019～2024年、2024～2029年、2034年
  • 身体検査
  • 画像検査
  • ラボテスト
  • 世界のウィルムス腫瘍市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
  • 手術
  • 化学療法
  • 放射線治療
  • 世界のウィルムス腫瘍市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
  • がん研究機関
  • 診断検査室
  • 病院
  • その他
  • 世界のウィルムス腫瘍市場：予後良好型組織像のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 片側性ウィルムス腫瘍
  • 両側性ウィルムス腫瘍
  • 腎芽細胞過形成
  • 世界のウィルムス腫瘍市場：退形成型組織像のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • びまん性退形成型ウィルムス腫瘍
  • 限局性退形成型ウィルムス腫瘍
  • 混合型退形成型ウィルムス腫瘍

第7章 地域別・国別分析

  • 世界のウィルムス腫瘍市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界のウィルムス腫瘍市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ウィルムス腫瘍市場：競合情勢
  • ウィルムス腫瘍市場：企業プロファイル
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medline Industries LP Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Apollo Hospital Overview, Products and Services, Strategy and Financial Analysis
    • Exelixis Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Abcam plc
  • Sino Biological Inc.
  • OriGene Technologies Inc.
  • Cell Signaling Technology Inc.
  • Proteintech Group Inc.
  • Santa Cruz Biotechnology Inc.
  • Novus Biologicals LLC
  • Recordati Rare Diseases
  • Getwell Pharmaceuticals
  • AdvaCare Pharma
  • Florencia Healthcare
  • Boster Biological Technology
  • NanoSmart Pharmaceuticals Inc.
  • BLK-Max Hospital
  • Plunes Healthcare

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • ウィルムス腫瘍市場2029：新たな機会を提供する国
  • ウィルムス腫瘍市場2029：新たな機会を提供するセグメント
  • ウィルムス腫瘍市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r35034

Wilms tumor, also known as nephroblastoma, is a form of kidney cancer that primarily affects children, most commonly under the age of 5. The tumor originates in the kidneys, which are responsible for filtering waste from the blood and producing urine. Wilms tumor is marked by the abnormal growth of kidney cells and can present with symptoms such as an abdominal mass, pain, fever, hematuria (blood in the urine), and elevated blood pressure.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The two main types of wilms tumor are favorable histology and anaplastic histology. Favorable histology indicates a better prognosis and a strong response to treatment, with high success rates typically achieved through surgery and chemotherapy. The tumor is classified into stages I through V and is diagnosed using methods such as physical examinations, imaging tests, and laboratory tests. Treatment options include surgery, chemotherapy, and radiation therapy. The disease is managed across various end-users, including cancer research institutes, diagnostic laboratories, hospitals, and other healthcare facilities.

The wilms tumor market research report is one of a series of new reports from The Business Research Company that provides wilms tumor market statistics, including the wilms tumor industry global market size, regional shares, competitors with the wilms tumor market share, detailed wilms tumor market segments, market trends, and opportunities, and any further data you may need to thrive in the wilms tumor industry. This wilms tumor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The wilms tumor market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.72 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increasing awareness about early cancer diagnosis, increasing government initiatives, rising prevalence of genetic predisposition, rising investments in pediatric oncology drug discovery, and rising healthcare expenditure on pediatric oncology treatments.

The wilms tumor market size is expected to see steady growth in the next few years. It will grow to $2.07 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to a growing focus on personalized medicine, increased use of radiotherapy techniques, a rising prevalence of lifestyle-related risk factors, an increase in the number of pediatric oncologists, and the expansion of awareness campaigns by healthcare organizations. Key trends anticipated during the forecast period include the development of CAR-T cell therapies, the introduction of novel chemotherapy regimens, the expansion of combination therapies, advancements in biomarker-driven diagnostics, and the integration of wearable health monitoring devices.

The growing incidence of pediatric cancer is expected to drive the expansion of the wilms tumor market in the coming years. Pediatric cancer refers to cancers occurring in children aged 0 to 14, characterized by the abnormal growth of cells in various organs and tissues. The rising prevalence is linked to factors such as environmental pollutants, genetic predisposition, infections, and immune system issues. These cases offer valuable insights into early diagnosis, genetic factors, and targeted treatments, contributing to higher survival rates and improved quality of life for affected children. For instance, in January 2025, the Cancer Network, a US-based cancer research organization, projected that approximately 9,550 children (aged 0-14 years) would be diagnosed with cancer in 2025, with an estimated 1,050 deaths. Thus, the increasing rate of pediatric cancer is fueling the growth of the Wilms tumor market.

Increasing healthcare expenditure is anticipated to accelerate the growth of the wilms tumor market. Healthcare expenditure refers to the total financial investment in medical services, equipment, drugs, and healthcare infrastructure over a specific time period. The upward trend in spending is driven by a higher prevalence of chronic diseases and a growing need for advanced treatment options. Enhanced healthcare spending facilitates better treatment of Wilms tumor by enabling early diagnosis, access to advanced therapies, and specialized medical care ultimately improving survival outcomes. It also supports ongoing research, innovation in treatment methods, and accessibility to targeted, affordable drugs. For example, in May 2024, the UK's Office for National Statistics reported a 5.6% nominal increase in healthcare spending from 2022 to 2023, compared to a 0.9% increase in 2022. As such, rising healthcare expenditure is contributing significantly to the growth of the Wilms tumor market.

In August 2023, the Kidney Cancer Association (KCA), a US-based organization committed to supporting kidney cancer patients, partnered with the Wilms Cancer Foundation (WCF) to enhance global initiatives in pediatric kidney cancer awareness, research, and treatment. The collaboration is focused on encouraging international cooperation, improving resources for healthcare providers, advancing early detection strategies, and promoting policy reforms aimed at better outcomes for pediatric kidney cancer. The Wilms Cancer Foundation, based in the US, advocates for children, families, and healthcare institutions affected by Wilms tumors, working to improve care and support across the board.

Major players in the wilms tumor market are Thermo Fisher Scientific Inc., Medline Industries LP, Agilent Technologies Inc., Apollo Hospital, Exelixis Inc., Abcam plc, Sino Biological Inc., OriGene Technologies Inc., Cell Signaling Technology Inc., Proteintech Group Inc., Santa Cruz Biotechnology Inc., Novus Biologicals LLC, Recordati Rare Diseases, Getwell Pharmaceuticals, AdvaCare Pharma, Florencia Healthcare, Boster Biological Technology, NanoSmart Pharmaceuticals Inc., BLK-Max Hospital, Plunes Healthcare.

North America was the largest region in the wilms tumor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the wilms tumor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The wilms tumor market consists of revenues earned by entities by providing services such as immunotherapy, post-treatment surveillance, psychosocial counseling, and treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The wilms tumor market includes sales of targeted therapy drugs, immunotherapy drugs, genetic testing kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wilms Tumor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wilms tumor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for wilms tumor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The wilms tumor market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Favorable Histology; Anaplastic Histology
  • 2) By Stages: Stage I; Stage II; Stage III; Stage IV; Stage V
  • 3) By Diagnosis: Physical Examination; Imaging Tests; Lab Tests
  • 4) By Treatment: Surgery; Chemotherapy; Radiation Therapy
  • 5) By End-User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals; Other End-Users
  • Subsegments:
  • 1) By Favorable Histology: Unilateral Wilms Tumor; Bilateral Wilms Tumor; Nephroblastomatosis
  • 2) By Anaplastic Histology: Diffuse Anaplastic Wilms Tumor; Focal Anaplastic Wilms Tumor; Mixed Anaplastic Wilms Tumor
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Medline Industries LP; Agilent Technologies Inc.; Apollo Hospital; Exelixis Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Wilms Tumor Market Characteristics

3. Wilms Tumor Market Trends And Strategies

4. Wilms Tumor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Wilms Tumor Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Wilms Tumor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Wilms Tumor Market Growth Rate Analysis
  • 5.4. Global Wilms Tumor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Wilms Tumor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Wilms Tumor Total Addressable Market (TAM)

6. Wilms Tumor Market Segmentation

  • 6.1. Global Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Favorable Histology
  • Anaplastic Histology
  • 6.2. Global Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stage I
  • Stage II
  • Stage III
  • Stage IV
  • Stage V
  • 6.3. Global Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Physical Examination
  • Imaging Tests
  • Lab Tests
  • 6.4. Global Wilms Tumor Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgery
  • Chemotherapy
  • Radiation Therapy
  • 6.5. Global Wilms Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Research Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Other End-Users
  • 6.6. Global Wilms Tumor Market, Sub-Segmentation Of Favorable Histology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Unilateral Wilms Tumor
  • Bilateral Wilms Tumor
  • Nephroblastomatosis
  • 6.7. Global Wilms Tumor Market, Sub-Segmentation Of Anaplastic Histology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diffuse Anaplastic Wilms Tumor
  • Focal Anaplastic Wilms Tumor
  • Mixed Anaplastic Wilms Tumor

7. Wilms Tumor Market Regional And Country Analysis

  • 7.1. Global Wilms Tumor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Wilms Tumor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Wilms Tumor Market

  • 8.1. Asia-Pacific Wilms Tumor Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Wilms Tumor Market

  • 9.1. China Wilms Tumor Market Overview
  • 9.2. China Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Wilms Tumor Market

  • 10.1. India Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Wilms Tumor Market

  • 11.1. Japan Wilms Tumor Market Overview
  • 11.2. Japan Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Wilms Tumor Market

  • 12.1. Australia Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Wilms Tumor Market

  • 13.1. Indonesia Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Wilms Tumor Market

  • 14.1. South Korea Wilms Tumor Market Overview
  • 14.2. South Korea Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Wilms Tumor Market

  • 15.1. Western Europe Wilms Tumor Market Overview
  • 15.2. Western Europe Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Wilms Tumor Market

  • 16.1. UK Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Wilms Tumor Market

  • 17.1. Germany Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Wilms Tumor Market

  • 18.1. France Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Wilms Tumor Market

  • 19.1. Italy Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Wilms Tumor Market

  • 20.1. Spain Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Wilms Tumor Market

  • 21.1. Eastern Europe Wilms Tumor Market Overview
  • 21.2. Eastern Europe Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Wilms Tumor Market

  • 22.1. Russia Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Wilms Tumor Market

  • 23.1. North America Wilms Tumor Market Overview
  • 23.2. North America Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Wilms Tumor Market

  • 24.1. USA Wilms Tumor Market Overview
  • 24.2. USA Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Wilms Tumor Market

  • 25.1. Canada Wilms Tumor Market Overview
  • 25.2. Canada Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Wilms Tumor Market

  • 26.1. South America Wilms Tumor Market Overview
  • 26.2. South America Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Wilms Tumor Market

  • 27.1. Brazil Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Wilms Tumor Market

  • 28.1. Middle East Wilms Tumor Market Overview
  • 28.2. Middle East Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Wilms Tumor Market

  • 29.1. Africa Wilms Tumor Market Overview
  • 29.2. Africa Wilms Tumor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Wilms Tumor Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Wilms Tumor Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Wilms Tumor Market Competitive Landscape And Company Profiles

  • 30.1. Wilms Tumor Market Competitive Landscape
  • 30.2. Wilms Tumor Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medline Industries LP Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Apollo Hospital Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Exelixis Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Wilms Tumor Market Other Major And Innovative Companies

  • 31.1. Abcam plc
  • 31.2. Sino Biological Inc.
  • 31.3. OriGene Technologies Inc.
  • 31.4. Cell Signaling Technology Inc.
  • 31.5. Proteintech Group Inc.
  • 31.6. Santa Cruz Biotechnology Inc.
  • 31.7. Novus Biologicals LLC
  • 31.8. Recordati Rare Diseases
  • 31.9. Getwell Pharmaceuticals
  • 31.10. AdvaCare Pharma
  • 31.11. Florencia Healthcare
  • 31.12. Boster Biological Technology
  • 31.13. NanoSmart Pharmaceuticals Inc.
  • 31.14. BLK-Max Hospital
  • 31.15. Plunes Healthcare

32. Global Wilms Tumor Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Wilms Tumor Market

34. Recent Developments In The Wilms Tumor Market

35. Wilms Tumor Market High Potential Countries, Segments and Strategies

  • 35.1 Wilms Tumor Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Wilms Tumor Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Wilms Tumor Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r35034_Wilms_Tumor_GMR_2025